Amdocs insider plans sale of 33,584 ordinary shares

Amdocs Limited insider Tamar Rappaport Dagim filed to sell up to 33,584 ordinary shares through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate value of $1,856,859.36.

Accepted by SEC EDGAR 08/06/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Amdocs Limited insider Tamar Rappaport Dagim filed to sell up to 33,584 ordinary shares through Oppenheimer & Co. Inc. on Nasdaq, with an aggregate value of $1,856,859.36. These shares were issued on 11/11/2023 upon vesting of RSUs for no cash consideration.

The filing also lists sales of 107,577 ordinary shares for $5,436,262.88 on 07/23/2026 and 12,780 ordinary shares for $702,902.56 on 07/28/2026 during the prior three months.

Key Figures

Planned shares to be sold: 33,584 shares Planned sale value: $1,856,859.36 RSU vesting date: 11/11/2023 +4 more

7 metrics

Planned shares to be sold 33,584 shares Ordinary shares of Amdocs Limited proposed for sale via Oppenheimer & Co. Inc.

Planned sale value $1,856,859.36 Aggregate value associated with the 33,584 ordinary shares to be sold

RSU vesting date 11/11/2023 Date on which the 33,584 shares were issued upon vesting of RSUs

Shares sold 07/23/2026 107,577 shares Ordinary shares sold by Tamar Rappaport Dagim on 07/23/2026

Value sold 07/23/2026 $5,436,262.88 Aggregate value of 107,577 shares sold on 07/23/2026

Shares sold 07/28/2026 12,780 shares Ordinary shares sold by Tamar Rappaport Dagim on 07/28/2026

Value sold 07/28/2026 $702,902.56 Aggregate value of 12,780 shares sold on 07/28/2026

Key Terms

Ordinary Shares, vesting of RSUs, No consideration, Nasdaq

4 terms

Ordinary Shares financial

"Ordinary Shares | Oppenheimer & Co. Inc. 85 Broad St."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

vesting of RSUs financial

"Shares issued upon vesting of RSUs"

No consideration financial

"No consideration, shares issued upon vesting of RSUs"

Nasdaq financial

"108448276 | 08/06/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing by DOX insider Tamar Rappaport Dagim report?

The filing reports a planned sale of 33,584 Amdocs Limited ordinary shares valued at $1,856,859.36. It also lists prior three-month sales totaling 120,357 shares for more than $6.1 million in aggregate proceeds.

How many Amdocs (DOX) shares are proposed to be sold and through whom?

Tamar Rappaport Dagim proposes to sell 33,584 ordinary shares of Amdocs Limited through Oppenheimer & Co. Inc.. The filing notes trading on Nasdaq and an aggregate value of $1,856,859.36 for this proposed sale.

How were the 33,584 Amdocs (DOX) shares being registered for sale originally acquired?

The 33,584 ordinary shares were issued on 11/11/2023 upon vesting of RSUs. The filing specifies there was no cash consideration paid for these shares when they were issued to the insider.

What Amdocs (DOX) share sales occurred in the last three months before this Form 144?

The filing lists two sales: 107,577 ordinary shares sold on 07/23/2026 for $5,436,262.88, and 12,780 ordinary shares sold on 07/28/2026 for $702,902.56, both by Tamar Rappaport Dagim.

What is the total reported value of recent Amdocs (DOX) share sales by the insider?

The filing shows $5,436,262.88 from the 07/23/2026 sale and $702,902.56 from the 07/28/2026 sale. The proposed additional $1,856,859.36 sale would further increase the disclosed transaction value if executed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001968313
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AMDOCS LTD
SEC File Number	001-14840
Address of Issuer	P.O BOX 263, HIRZEL HOUSE, SMITH STREET ST. PETER PORT GUERNSEY 0
Phone	011-44-1481-728444
Name of Person for Whose Account the Securities are To Be Sold	Tamar Rappaport Dagim
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	33584	1856859.36	108448276	08/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	11/11/2023	Shares issued upon vesting of RSUs	AMDOCS LTD			33584	11/11/2023	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Tamar Rappaport Dagim P.O BOX 263, HIRZEL HOUSE, SMITH STREET ST. PETER PORT Y7 0	Ordinary Shares	07/23/2026	107577	5436262.88
Tamar Rappaport Dagim P.O BOX 263, HIRZEL HOUSE, SMITH STREET ST. PETER PORT Y7 0	Ordinary Shares	07/28/2026	12780	702902.56

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b5-1 trading plan adopted on 06/23/2026
Date of Notice	08/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/23/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Tamar Rappaport Dagim By: /s/ Liron Avigdor Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)